GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (OTCPK:HNGZY) » Definitions » Shiller PE Ratio

Hangzhou Tigermed Consulting Co (Hangzhou Tigermed Consulting Co) Shiller PE Ratio : 38.18 (As of Jun. 19, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Shiller PE Ratio?

As of today (2024-06-19), Hangzhou Tigermed Consulting Co's current share price is $4.20. Hangzhou Tigermed Consulting Co's E10 for the quarter that ended in Mar. 2024 was $0.11. Hangzhou Tigermed Consulting Co's Shiller PE Ratio for today is 38.18.

The historical rank and industry rank for Hangzhou Tigermed Consulting Co's Shiller PE Ratio or its related term are showing as below:

HNGZY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 28.75   Med: 100.14   Max: 333.96
Current: 37.98

During the past years, Hangzhou Tigermed Consulting Co's highest Shiller PE Ratio was 333.96. The lowest was 28.75. And the median was 100.14.

HNGZY's Shiller PE Ratio is ranked worse than
68.75% of 80 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.68 vs HNGZY: 37.98

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hangzhou Tigermed Consulting Co's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.037. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.11 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hangzhou Tigermed Consulting Co Shiller PE Ratio Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Shiller PE Ratio Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 283.12 142.75 92.88 40.98

Hangzhou Tigermed Consulting Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.41 50.62 49.86 40.98 38.84

Competitive Comparison of Hangzhou Tigermed Consulting Co's Shiller PE Ratio

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Shiller PE Ratio falls into.



Hangzhou Tigermed Consulting Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hangzhou Tigermed Consulting Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=4.20/0.11
=38.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Tigermed Consulting Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Hangzhou Tigermed Consulting Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.037/115.2271*115.2271
=0.037

Current CPI (Mar. 2024) = 115.2271.

Hangzhou Tigermed Consulting Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.007 98.200 0.008
201409 0.008 98.900 0.009
201412 0.010 99.000 0.012
201503 0.010 99.900 0.012
201506 0.010 99.500 0.012
201509 0.008 100.500 0.009
201512 0.011 100.600 0.013
201603 0.009 102.200 0.010
201606 0.008 101.400 0.009
201609 0.005 102.400 0.006
201612 0.009 102.600 0.010
201703 0.009 103.200 0.010
201706 0.015 103.100 0.017
201709 0.016 104.100 0.018
201712 0.021 104.500 0.023
201803 0.020 105.300 0.022
201806 0.025 104.900 0.027
201809 0.029 106.600 0.031
201812 0.030 106.500 0.032
201903 0.029 107.700 0.031
201906 0.040 107.700 0.043
201909 0.033 109.800 0.035
201912 0.059 111.200 0.061
202003 0.048 112.300 0.049
202006 0.140 110.400 0.146
202009 0.057 111.700 0.059
202012 0.075 111.500 0.078
202103 0.080 112.662 0.082
202106 0.143 111.769 0.147
202109 0.093 112.215 0.095
202112 0.198 113.108 0.202
202203 0.095 114.335 0.096
202206 0.117 114.558 0.118
202209 0.068 115.339 0.068
202212 0.066 115.116 0.066
202303 0.096 115.116 0.096
202306 0.133 114.558 0.134
202309 0.077 115.339 0.077
202312 0.024 114.781 0.024
202403 0.037 115.227 0.037

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hangzhou Tigermed Consulting Co  (OTCPK:HNGZY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Hangzhou Tigermed Consulting Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co (Hangzhou Tigermed Consulting Co) Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co (Hangzhou Tigermed Consulting Co) Headlines